When teaching a client about a new prescription for Celecoxib, which of the following information should the nurse include?

Correct Answer: A

Rationale: The nurse should educate the client that taking Celecoxib increases the risk of a myocardial infarction due to its suppression of vasodilation. This medication belongs to the class of NSAIDs known to have cardiovascular risks, including an increased risk of heart attacks. Therefore, it is essential for the nurse to emphasize this potential adverse effect during client teaching to ensure the client is aware of the associated risks.

Correct Answer: D

Rationale: Amitriptyline is known to cause orthostatic hypotension, a sudden drop in blood pressure when moving from lying down or sitting to a standing position. Monitoring for orthostatic hypotension is crucial to prevent falls and related injuries. Educating the client about moving slowly and changing positions gradually can help mitigate this adverse effect.

Correct Answer: D

Rationale: In this scenario, the correct answer is D) Liver function test. Acarbose is a medication used to treat type 2 diabetes mellitus by inhibiting the enzymes responsible for breaking down carbohydrates. This medication can potentially affect liver function, so it is crucial to monitor the client's liver enzymes regularly to detect any signs of liver damage or toxicity. Option A) WBC (White Blood Cell) count is not directly related to the monitoring of Acarbose therapy for diabetes. Changes in WBC count are typically associated with infections or immune system disorders rather than the side effects of this medication. Option B) Serum potassium levels are not specifically impacted by Acarbose therapy. Monitoring potassium levels is more relevant in clients taking medications like diuretics or certain heart medications that can affect potassium balance. Option C) Platelet count is not typically affected by Acarbose therapy. Platelet counts are usually monitored in conditions related to clotting disorders or certain medications that can impact platelet function. Educationally, understanding the rationale behind monitoring specific laboratory tests for clients on different medications is essential for nurses to provide safe and effective care. By comprehending the potential side effects and monitoring requirements of medications like Acarbose, nurses can proactively assess and manage any adverse effects, ensuring optimal patient outcomes.

Correct Answer: D

Rationale: In the case of a client with Hypothyroidism starting Levothyroxine in a long-term care facility, the nurse should expect the dosage schedule to start with a low dose (Option D) that will be gradually increased. This is the correct answer because initiating treatment for Hypothyroidism with Levothyroxine typically involves a cautious approach to prevent adverse effects like cardiac complications or hyperthyroidism. Option A, starting at a high dose and tapering, is incorrect because it poses a higher risk of adverse effects and does not align with standard practice guidelines for Levothyroxine initiation. Option B, remaining on the initial dosage, is also incorrect as dosages are usually adjusted based on the client's response to treatment. Option C, adjusting the dosage daily based on blood levels, is not typically done as it takes time for Levothyroxine to reach therapeutic levels in the body. From an educational perspective, understanding the rationale behind the gradual increase in Levothyroxine dosage is crucial for nursing practice. It ensures safe and effective medication management, highlights the importance of monitoring for signs of hyperthyroidism or cardiac issues, and emphasizes the need for ongoing assessment and dosage adjustments based on the client's clinical response. This approach aligns with evidence-based pharmacological principles and promotes optimal client outcomes in the long-term care setting.

Correct Answer: D

Rationale: The correct answer is D, Rotavirus vaccine. The series for the Rotavirus vaccine is completed prior to the first birthday as it is only administered to infants less than 8 months of age. This vaccine provides protection against severe diarrhea and vomiting caused by rotavirus infection, which is common in infants and young children.